Halline A G, Dudeja P K, Brasitus T A
Department of Medicine, University of Chicago, IL.
Biochem J. 1989 Apr 15;259(2):513-8. doi: 10.1042/bj2590513.
The effects of chronic inhibition of ornithine decarboxylase (ODC) by the specific inhibitor difluoromethylornithine (DFMO) in the rat colon and small intestine on mucosal contents of polyamines, decarboxylated S-adenosylmethionine (decarboxylated AdoMet) and S-adenosylmethionine decarboxylase (AdoMet decarboxylase) activity were studied. Administration of 1% DFMO in the drinking water for 10 or 15 weeks resulted in inhibition of ODC and decreases in intracellular putrescine and spermidine contents in both proximal and distal segments of small intestine and colon. At both time points DFMO administration resulted in a dramatic stimulation of AdoMet decarboxylase activity and a rise in decarboxylated AdoMet content in the proximal and distal small-intestinal segments compared with controls, which was not seen in either colonic segment of DFMO-treated animals. This differential stimulation of AdoMet decarboxylase by DFMO in the small intestine and colon could not be entirely explained on the basis of differences in polyamine contents, which are known to regulate this enzyme activity. Kinetic and inhibition studies of AdoMet decarboxylase in control small and large intestine revealed that: (1) there was no difference in Vmax. values between the tissues; (2) the Km for AdoMet was higher in the small intestine than in the colon; and (3) the Ki for product inhibition by decarboxylated AdoMet was higher in the small intestine than in the colon. These results suggest that the differential stimulation of AdoMet decarboxylase by DFMO in the small intestine and colon may be due to different isoenzymes and could play a significant role in the regulation of polyamine contents throughout the gut.
研究了特异性抑制剂二氟甲基鸟氨酸(DFMO)对大鼠结肠和小肠中鸟氨酸脱羧酶(ODC)的慢性抑制作用,及其对多胺、脱羧S-腺苷甲硫氨酸(脱羧AdoMet)的黏膜含量和S-腺苷甲硫氨酸脱羧酶(AdoMet脱羧酶)活性的影响。在饮用水中给予1%的DFMO 10或15周,导致小肠和结肠近端及远端节段的ODC受到抑制,细胞内腐胺和亚精胺含量降低。在两个时间点,与对照组相比,给予DFMO均导致近端和远端小肠节段的AdoMet脱羧酶活性显著增强,脱羧AdoMet含量升高,而在接受DFMO治疗的动物的结肠节段均未观察到这种情况。DFMO对小肠和结肠中AdoMet脱羧酶的这种差异刺激,不能完全用已知可调节该酶活性的多胺含量差异来解释。对对照小肠和大肠中AdoMet脱羧酶的动力学和抑制研究表明:(1)组织之间的Vmax值没有差异;(2)小肠中AdoMet的Km高于结肠;(3)脱羧AdoMet对产物抑制的Ki在小肠中高于结肠。这些结果表明,DFMO对小肠和结肠中AdoMet脱羧酶的差异刺激可能是由于不同的同工酶,并且可能在整个肠道多胺含量的调节中起重要作用。